Şunu aradınız:: in patients who expressed a protein called (İngilizce - Danca)

praluent blocks a protein called pcsk9.
praluent hæmmer et protein, der hedder pcsk9

low levels in the blood of a protein called „albumin‟,
lave niveauer i blodet af et protein, der hedder „albumin‟

the active ingredient in avonex is a protein called interferon beta-1a.
det aktive stof i avonex er et protein, der kaldes interferon beta-1a.

deltyba must not be used in patients who have low levels of albumin (a blood protein).
deltyba må ikke anvendes hos patienter med lavt indhold i blodet af proteinet albumin.

it can only be used in patients whose cancer has a change (mutation) in a protein called “braf”.
det kan kun bruges af patienter, hvis kræftsygdom har en ændring (mutation) i et protein, der kaldes braf.

caps are a group of diseases where patients have a defect in the gene that produces a protein called cryopyrin.
caps er en gruppe af sygdomme, hvor patienter har en fejl i det gen, der danner et protein kaldet kryopyrin.

firazyr is used in patients whose angioedema is linked to naturally low levels of a protein called ‘c1 esterase inhibitor’.
firazyr anvendes hos patienter hvis angioødem er forbundet med naturligt lave niveauer af et protein kaldet ”c1 esterase- hæmmer”.

alirocumab has been designed to attach to a protein called ‘pcsk9’.
alirocumab er udformet, så det bindes til proteinet "pcsk9".

ttr amyloid polyneuropathy is caused by a protein called ttr that does not work properly.
ttr amyloid polyneuropati skyldes, at et protein, som hedder ttr, ikke fungerer rigtigt.

it is used in patients whose cancer cells have a mutation in the genes that make a protein called epidermal growth factor receptor (egfr).
det anvendes til patienter, hvis kræftceller har en mutation i generne, som fremstiller et protein kaldet epidermal vækstfaktorreceptor (egfr).

the cords in the palm of patients with dupuytren’s contracture and the plaques in peyronie’s disease are made of fibres of a protein called collagen.
strengene i håndfladen hos patienter med dupuytrens kontraktur og plakkene ved peyronies sygdom består af fibre af et protein, der kaldes kollagen.

alprolix is a medicine used to treat and prevent bleeding in patients with haemophilia b, an inherited bleeding disorder caused by lack of a clotting protein called factor ix.
alprolix er et lægemiddel til behandling og forebyggelse af blødning ved den arvelige blødningsforstyrrelse hæmofili b, der skyldes mangel på blodstørkningsproteinet faktor ix.

it works by stimulating the body to produce a protein called metallothionein in the cells lining the gut.
det virker ved at stimulere kroppen til at danne et protein, der kaldes metallothionein, i tarmvæggenes celler.

in pnh, patients have a defect in a protein (called cd59) on the surface of their red blood cells that normally stops complement from attacking the cells.
ved pnh har patienterne en fejl i proteinet cd59 på overfladen af de røde blodceller.normalt vil dette protein forhindre komplement i at angribe cellerne.

tagrisso is used in patients whose cancer is advanced or has spread and who have the t790m mutation, a particular change in the gene for a protein called epidermal growth factor receptor (egfr).
tagrisso anvendes hos patienter, som har fremskreden eller udbredt kræft og har mutationen t790m, der er en særlig forandring i genet for proteinet epidermal vækstfaktor-receptor (egfr).

palivizumab has been designed to bind to a protein called ‘ fusion protein a ’ on the surface of rsv.
palivizumab er udformet, så det bindes til et protein, der kaldes fusionsprotein a, på overfladen af rsv.

palivizumab has been designed to attach to a protein called ‘fusion protein a’ on the surface of rsv.
palivizumab er udformet, så det bindes til et protein, der kaldes fusionsprotein a, på overfladen af rsv.

tarceva is a medicinal product used to treat cancer by preventing the activity of a protein called epidermal growth factor receptor.
tarceva er et lægemiddel som anvendes til behandling af kræft ved at forhindre aktiviteten af et protein, som kaldes epidermal vækstfaktor.

these included removal of the use of a protein called albumin, which is produced from human blood, from the manufacturing process.
lægemidlets navn blev desuden ændret fra refacto til refacto af.

flixabi works by blocking the action of a protein called ‘tumour necrosis factor alpha’ (tnfα).
flixabi virker ved at blokere virkningen af et protein, der hedder ”tumornekrosefaktor alfa” (tnfα).